Catecholamines present in the mammalian ovary are involved in many normal aspects of ovarian functions, including initial follicle growth, steroidogenesis and pathological states such as polycystic ovary syndrome (PCOS). Sympathetic nerve fibers are the largest source of norepinephrine (NE), but not the only one. Surgical denervation of the rat ovary, reduces, but does not eliminate, the ovarian content of NE. The aim of this work is to explore which intraovarian cells may participate in the ovarian NE homeostasis and the mechanisms involved.
Introduction
The sympathetic innervation of the mammalian ovary has been involved in many aspects of the regulation of ovary functions, including steroidogenesis and early follicular development (1, 2) .
In rats, these actions are performed mainly by norepinephrine (NE) and vasoactive intestinal peptide (VIP), which are contained in and released from nerve fibers. NE acts on ß2-adrenergic receptors present in theca and granulosa cells from rat ovary and stimulates the production of progesterone and androgens, but not the secretion of estradiol (1) (2) (3) (4) . In contrast to NE and acting on its own receptors, VIP stimulates estradiol and progesterone release from cultured granulosa cells and whole ovaries in vitro (5) . Recent evidence has confirmed a role for VIP in the control of ovarian cyclic steroid production in adult cycling rats (6) . These neurotransmitters may also facilitate the follicular development, as seen, for example, in the inhibition of follicular growth following ovarian denervation (7) (8) (9) .
In the rat, a substantial fraction of the sympathetic innervation, targeting the ovary, is provided by neurons of the celiac ganglion and travels through the superior ovarian nerve (SON). Sympathetic innervation represents almost 90% of the NE present in the ovary, and yet, after surgical denervation, NE levels still remain over 10-15% (10) , suggesting the existence of intraovarian cells participating in ovarian NE homeostasis.
Furthermore, oocytes could be in part responsible for this, as at least in monkeys they showed to take up dopamine, through membrane dopamine transporter (DAT) and synthesize NE (via dopamine-beta hydroxylase) (11) . These mechanisms could have special relevance to pathological states, such as polycystic ovary syndrome (PCOS), the most frequent ovarian pathology in women during their fertile years. Using a rat model of PCO, an increased ovarian sympathetic tone has been described, associated with the development and maintenance of PCO (12) . In addition, these findings have been recently extended to the women (13) , supporting a role for NE and catecholamines in maintaining the pathological condition. It is important to consider that sympathetic denervation or electrolytic lesion in the sympathetic pathway of the ovarian nerves in the rat reverse the formation of cyst (14, 15) . However, the responsible for an increased sympathetic tone in PCOS could also lie within the ovary itself and may include an increased activity of intraovarian neurons (found in some species and Wistar rats) or other unknown intraovarian compartment which could regulate NE homeostasis. The present study was designed to address these issues and to search for others ovarian sources for NE in two strains of rats and extend the study to human beings.
Materials and Methods

Animals
Ovaries from adult and prepubertal Wistar and Sprague-Dawley rats, derived from stocks maintained at the University of Chile, were used. The ovaries of Wistar rats are reported to contain neuron-like cells, while Sprague-Dawley rats lack of these cells (16). The ovaries derived from adult Wistar and Sprague-Dawley rats were used either to quantify NE, incorporate and release NE, RT-PCR procedures and/or fixed for immunohistochemistry (n=30 for each rat strain), whereas the ovaries from prepubertal Wistar and Sprague-Dawley rats were used to isolate granulosa cells (n=12 for each rat strain). Some of the Wistar and Sprague Dawley rats underwent ovarian denervation (SONX) 11-12 days before the experiments. This procedure was intended to eliminate the extrinsic contribution of NE via the sympathetic innervation of the ovary. For the procedure, rats were anesthetized with Xilaxine (10mg/kg) and Ketamine (90mg/kg) and the ovaries were denervated under dorsal approximation as described (14, 17) . All the animals were euthanized by decapitation. The ovaries were rapidly removed, cleaned of adherent tissue and immediately used for release and incorporation experiments. Other ovaries of the same age were frozen at -80°C for total RNA isolation and NE quantification or embedded in Zamboni's fixative for immunohistochemistry. In addition, Bouin's fixed and paraffin embedded ovaries from adult Sprague-Dawley rats we used for the preparation of sections and immunohistochemistry. These samples had been used in previous studies (18) 
Rat granulosa cells
Rat granulosa cells were purified as previously described (14, 19) . To eliminate the contribution of luteal cells present in the ovary of adult rats, the ovaries of prepubertal (25 days old) Sprague-Dawley rats were used as recommended (19). The ovaries were punched with a needle and squeezed out gently to obtain the granulosa cells. Cells were suspended in 1 ml of Krebs-Ringer Buffer (KRB) and centrifuged at 3000 xg for 5 min and the pellet of cell was suspended in one ml of KRB. Cells were counted and aliquots of 50,000 cells were used for the NE release and incorporation experiments. RNA was isolated from several batches of 100,000 cells each.
Human granulosa cells
Human granulosa cells were obtained from follicular aspirates of women undergoing IVF, as described (20, 21). They were separated by centrifugation at 560 xg for 3 min and subsequently washed in serum-free DMEM/Ham's F-12 medium (1:1, Sigma, Deisenhofen, Germany). Washed cells were suspended in culture medium supplemented with penicillin (100 U/ml), streptomycin (100 μg/ml) and 10 % fetal calf serum as previously described (22). The Ethics Committee of the Ludwig-Maximilians University of Munich had approved the use of the cells for scientific experiments, and written consent of the patients was obtained. Cells from 2-4 patients were pooled for all experiments.
Uptake and release of NE
The procedure employed has been previously described (23-25). In brief, the ovaries were preincubated for 20 min in KRB, pH 7,4, gassed with 95%O 2 -5%CO 2 , and then incubated for 30 min at 37°C with 2 μCi 3 HNE (Dupont/NEN, Boston, MA). After washing the tissue in KRB (six washes of 10 min each) to remove non-incorporated radioactivity, the ovaries were transferred to a thermorregulated superfusion chamber and perifused at a flow rate of 1.5 ml/min for 10 min with KRB plus 10 mM tetraethylammonium, a potassium channel blocker which enhances the release of NE from nerve terminals in response to electrical stimulation (26). One-minute fractions were collected. After 3 min, the gland was subjected to a train of monophasic electrical pulses (80 V, 10 HZ, 10 msec/pulse for 1 min), delivered through a parallel set of platinum electrodes and generated by a Grass S-4 stimulator (Grass Instruments, Quincy, MA). One minute fractions were collected for 5 min more. In each experiment, ovaries from SONX and control rats were simultaneously stimulated in parallel superfusion chambers. At the end of the experiment, the ovaries were homogenized in 0.4 N perchloric acid, and 3 
Effect of cocaine on ovarian incorporation and release of
HNE
In order to elucidate the effect of cocaine on the NE incorporation by the ovary, rat ovaries were halved. One half was incubated with KRB and the other with KRB plus 10 μM cocaine (Sigma Chem. Co., St Louis, MO) for 10 min at 37°C. Later, the ovaries were incubated with 2 μCi/ml 3 HNE (levo- [7,8- 
Incorporation of NE in isolated granulosa cells
In order to analyze the releasing capacity of NE in granulosa cells, they were isolated them from the Sprague-Dawley rats' ovaries as previously explained.
Granulosa suspension was incubated in 1 ml of KRB, containing 0.25 μCi/ml of 3 HNE (levo- [7, H]-norepinephrine, Amersham Biosciences, UK) for 30 min at 37°C.
Granulosa cell suspension was centrifuged and the cellular pellet was washed 5 times by suspension with 1 ml of KRB during 10 min followed by 5 min centrifugation (3,000 xg) each time to eliminate non-incorporated 
NE determination by HPLC
To quantify the concentration of NE in the ovaries, they were homogenized in 
RNA preparation, reverse transcription and polymerase chain reaction (RT-PCR) for rat tissues
RT-PCR was used to determine whether mRNAs encoding Net (SLC6A2), Dat (SLC6A3) and Vmat2 (SLC18A2) are present in the rat ovary, granulosa cells and/or celiac ganglion. The celiac ganglion was dissected as described earlier (27). Total RNA was extracted as recommended (28). A total of five μg RNA were subjected to reverse transcription at 42°C for 60 min, using 1. RT-PCR products were separated on 2.0 % agarose gels, stained with ethidium bromide, and photographed digitally. The identities of all PCR products were verified by direct sequencing, using one of the specific primers.
RT-PCR for human granulosa cells
Total RNA from several batches of cultured granulosa cells (3 and 4 days after isolation) was prepared using RNEasy kit (Qiagen, Hilden, Germany). As previously described (20), total RNA (200-500 ng) was subjected to reverse transcription, using random primers (pdN6) and Superscript-RT II (Life Technologies, Karlsruhe, Germany). Commercial human brain and ovary cDNAs (BD CLONTECH, Inc., Heidelberg, Germany) were used as well.
PCR amplifications (see table 2 ) consisted of 34 cycles of denaturing (at 94°C for 60 sec), annealing (at 60°C for 60 sec), and extension (at 72°C for 60 sec). Reaction tubes lacking of RT product input were used as PCR controls. In some cases, control reactions, in which cDNA was replaced by RNA, were also performed. The PCR reaction products were separated on 2.0 % agarose gels and visualized with ethidium bromide. The identities of all PCR products were verified by direct sequencing, using one of the specific primers
Immunocytochemistry of human granulosa cells
DAT protein in cultured human granulosa cells was examined by immunocytochemistry using a commercially available polyclonal antiserum (rabbit anti-DAT, Alpha Diagnostic Intl. Inc, distributed by BIOTREND, Cologne, Germany, 1.200 -1:500), as described (30). This antiserum recognizes rat and mouse DAT, but crossreacts with human DAT, as their sequences posses a 72% of homology. Cells were cultured for this purpose on glass coverslips, fixed (4 % paraformaldehyde in 10 mM PBS) and used after rinsing in 10 mM PBS (pH 7.4). Incubations with the antiserum were performed overnight in a humidified chamber at 4°C. After washing steps, a fluorescein isothiocyanate-labeled second goat anti-rabbit antiserum was used. For control purposes, the first antiserum was omitted, and incubations with normal rabbit serum were carried out instead. In a similar way, rabbit anti-NET antiserum /Biozol, Eching, Germany, ab41559; 1.500-1:1000) was employed. Sections were examined with a Zeiss Axiovert microscope (Zeiss, Oberkochen, Germany), equipped with a fluorescein filter set.
Immunohistochemistry for DAT and NET in rat and human ovaries
Rat ovaries sections (Wistar and Sprague-Dawley) and human ovarian sections (from the tissue collection of the Anatomical Institute, Munich; (21, 30-32) were subjected to immunohistochemistry. The same specific DAT and NET antisera used for human granulosa cells were used for these tissues, according to the procedure previously reported (21, 30, 31). In addition, VMAT2 rabbit antiserum was used (Phoenix Pharmaceuticals, Mountain View, CA; 1:1.000 -1:2:000). In brief, sections of 6 μm were deparaffinized and endogenous peroxidase activity was blocked. After that, those sections were submitted to antigen retrieval by heating in citrate buffer (1. 
Statistical Analysis
The results were expressed as mean ± standard error. Comparisons between several groups were made using the Student t test, considering p<0.05 as significant.
Results
Ovarian NE uptake studies and effects of cocaine
Surgical denervation of the ovary by SONX 11-12 days prior to the NE uptake-and release-experiments was performed in order to eliminate the most important source of extraovarian NE (sympathetic innervation via SON). As shown in figure 1, (14)). However, the amount of The capacity for incorporating NE after blocking the NET and DAT catecholamine transporters with cocaine, a well-known inhibitor of NE and DA neuronal uptake (33, 34) was then compared. A decrease of an 85% was found in the NE incorporation capacity, an effect which had the same magnitude for control and SONX ovaries (table   3 ). In the ovary of Sprague-Dawley rats, cocaine produced a similar effect but in a lower magnitude (56% for control and 58% for denervated ovaries). Thus, we conclude that a cocaine-sensitive up-take mechanism exists and, although in the Wistar and Sprague-Dawley rat ovaries the sympathetic innervation is very important as a source of norepinephrine, yet there must be other intraovarian cellular structures which can take up and incorporate NE.
Identification of DAT, NET and VMAT2 in rat granulosa cells
The effects of cocaine, a blocker for NET and DAT, suggested the presence and involvement of these membrane transporters in the ovary. Thus, immunohistochemical studies attempted to localize NET and DAT in the ovary of Wistar and Sprague-Dawley rats (Figure 2Aa and 2Ba) . Immunoreactive NET, DAT and VMAT2 proteins were mainly located in granulosa cells and the oocyte in Wistar rats. Signals were found in luteal cells as well, albeit with a lower intensity, Although it was found DAT and VMAT2 immunoreactivity in the ovary of Sprague-Dawley rats, immunoreactivity for NET was not found. Signals were absent in negative controls indicating the specificity of anti-NET, anti-DAT and anti-VMAT2. However, Figure 2Ab and 2Bb shows that Dat and Net mRNAs are present in the ovary of both strains of rats, in the isolated granulosa cells and, as expected, in the celiac ganglion.
Furthermore, mRNA for the vesicular transporter (Vmat2) was also detected in both, the ovary and isolated granulosa cells.
Uptake and release studies in rat granulosa: Uptake is blocked by cocaine and the release of NE is calcium-dependent
Because On the other hand, granulosa cells (through membrane receptors to DA and NE) are under the control of catecholamines, which are mainly derived from extrinsic sympathetic nerves or released from intrinsic sources, present in at least some species (16, 39) and could travel through the blood stream to the ovary from the adrenal.
However, neither sympathetic innervation nor neuron-like cells or blood vessels are found in direct contact with granulosa cells and do not penetrate the basal lamina, which separates the granulosa and theca cell compartments. This implies that, first, catecholamines must diffuse through this structural barrier in order to reach granulosa cells. While in small follicles this may be an strong possibility, the diffusion distance increases in multilayered growing follicles.
Here, a novel evidence for granulosa cells of ovarian follicles, including large follicles is shown. These follicles will become a cellular compartment, which is able to regulate intrafollicular catecholamine homeostasis in an unexpected way. We show that granulosa cells take up NE, store it and, upon depolarization, release it. The presence of these mechanisms in the ovary of Wistar and Sprague-Dawley rats and the prerequisites for this mechanism in human ovary strongly suggest that these cells serve as unexplored catecholamine-storing cells within the ovarian follicle, ensuring that NE and/or DA are being present in the granulosa cell compartment, which lacks direct contact to catecholamine sources, such as innervation. This perspective would be in accordance with a role of NE and DA as important factors of the follicular microenvironment.
Many studies have demonstrated that after ovarian denervation (surgical cutting of the sympathetic nerves arriving to the ovary) there is a residual intraovarian NE independent of the rat's strain used in the study (3, 40) . This implies the presence of another intraovarian catecholamine storage compartment besides nerve fibers, which degenerate after the denervation procedure. Intraovarian neuron-like cell bodies have been described only in the ovary of Wistar but not in Sprague-Dawley rats (41) and could be used for such storage of NE. As we previously demonstrated in the SpragueDawley rat (14) and in the present study for the Wistar rat, we found a similar decrease in endogenous NE after surgical denervation suggesting that the remaining NE is still present in another cellular compartment present in both ovaries.
While granulosa cells are not able to perform de novo synthesis of catecholamines, as they do not express tyrosine-hydroxylase (TH), they were found to possess DAT and NET. Interestingly, granulosa cells from both strains of examined rats express DAT and NET. However, the amount of mRNA and protein for NET seem to be low The transmembrane transporters DAT and NET mediate Na + -dependent reaccumulation of released catecholamines into the presynaptic terminals of neurons (44) in the nervous system. Functionality of ovarian DAT and NET was proved by the ability of cocaine to block NE uptake in isolated rat granulosa cells. NE is the largest catecholamine detected in the rat ovary (45) and that was the reason it was chosen to perform the experimental uptake and release studies using radioactive NE. Even though NET has a preference for NE, and DAT for DA (42), both catecholamines can be taken up by the transporters. As both transporters are inhibited by cocaine, a specific involvement of NET or DAT in the uptake of NE or DA in rat granulosa cells
can not be concluded for the reasons mentioned above. However, it is possible to speculate that due to the strong expression of DAT, in contrast to NET, in human granulosa cells, the human ovary besides containing NE also contains a high concentration of DA (46). Thus, in a DAT-mediated uptake, granulosa cells are likely to uptake not only DA, but also NE and could make these cells a storage compartment for these catecholamines. The concept that granulosa cells are targets for neurotransmitters is not a new one.
However, the idea that these cells, which are present in a compartment of the ovary and lacks direct innervation, can take up, store and release neurotransmitter, including catecholamines is only an emerging insight. From a pathological perspective, it has been previously postulated that development and maintenance of polycystic ovary is associated with an activation of sympathetic nerves (12) . Adult rats exposed to chronic stress develop a polycystic condition similar in morphological aspect to the human PCOS, suggesting a higher sympathetic input and role in the derangement of follicular development characteristically seen in human being with the pathology (15) . From this point of view, it has recently been demonstrated that women with PCOS have a higher sympathetic tone (13) . Bearing this in mind, granulosa cells as a cellular compartment in general with the ability of storing and releasing NE, could serve as a reserve to maintain a higher availability of catecholamines in the follicles. Experiments are currently in progress to examine this hypothesis.
In summary, this study shows that ovarian non-neuronal, endocrine granulosa cells can take up NE, presumably derived from several potential sources, and can then serve as an intrafollicular catecholamine-storing compartment. Exocytotic NE release from granulosa cells can occur in a regulated manner, as described for neuronal cells.
These results provide novel insights to the neuronal nature of granulosa cells and suggest a more complex involvement of catecholamines in normal ovarian functions as Primer information for human SNAP25, DAT (SLC6A3), NET (SLC6A2) and 
VMAT2 (SLC18A2)
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